23andMe to Merge with Virgin Group’s VG Acquisition Corp. to Become Publicly-Traded Company Set to Revolutionize Personalized Healthcare and Therapeutic Development through Human Genetics
Avec une IPO la société va passer un cap en cette période ou les BioTech se portent très bien.
23andMe is a leading consumer genetics and research company that offers a personalized health and wellness experience and has built a premier genetic
via Chrome : lire l’article source